These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8617701)

  • 1. Diphenhydramine dependence: a need for awareness.
    de Nesnera AP
    J Clin Psychiatry; 1996 Mar; 57(3):136-7. PubMed ID: 8617701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
    Chamorro García L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine dependence and withdrawal: a case report.
    Yargic I; Caferov C
    Subst Abus; 2011 Jul; 32(3):168-9. PubMed ID: 21660879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compliance with treatment in schizophrenia and mood disorders].
    Sorvaniemi M; Kampman O
    Duodecim; 2000; 116(3):277-84. PubMed ID: 11764451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombocytopenia associated with clozapine and fluphenazine.
    Mihaljević-Peles A; Jakovljevic M; Mrsic M; Sagud M
    Nord J Psychiatry; 2001; 55(6):449-50. PubMed ID: 11859840
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysphagia: a rare form of dyskinesia?
    Nieves JE; Stack KM; Harrison ME; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):199-201. PubMed ID: 17522565
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiramycin-associated acute dystonia during neuroleptic treatment.
    Benazzi F
    Can J Psychiatry; 1997 Aug; 42(6):665-6. PubMed ID: 9288434
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of oral glucose tolerance test in patient with schizophrenia.
    Margetić B; Aukst-Margetić B; Badanjak A
    Psychiatr Danub; 2005 Jun; 17(1-2):94-6. PubMed ID: 16395850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible dysphagia associated with neuroleptic treatment.
    Stewart JT
    J Am Geriatr Soc; 2001 Sep; 49(9):1260-1. PubMed ID: 11559393
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluphenazine decanoate causing atrioventricular block.
    Rao AV
    Indian Heart J; 1996; 48(6):713-4. PubMed ID: 9062027
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies with fluphenazine enanthate: II. Relapse rate in patients deprived of medication.
    Ravaris CL; Weaver LA; Brooks GW
    Am J Psychiatry; 1967 Aug; 124(2):248-9. PubMed ID: 4952779
    [No Abstract]   [Full Text] [Related]  

  • 18. Benzodiazepine use, abuse, and dependence.
    O'brien CP
    J Clin Psychiatry; 2005; 66 Suppl 2():28-33. PubMed ID: 15762817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse.
    Voruganti LN; Heslegrave RJ; Awad AG
    J Nerv Ment Dis; 1997 Jul; 185(7):463-5. PubMed ID: 9240366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.